This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Aug 12;356(9229):526-7.

doi: 10.1016/S0140-6736(00)02573-3.

Oral tolerance and autoimmune diabetes--will hope triumph over experience?

E A Gale¹

Affiliations

PMID: 10950225
DOI: 10.1016/S0140-6736(00)02573-3

Comment

Oral tolerance and autoimmune diabetes--will hope triumph over experience?

E A Gale. Lancet. 2000.

. 2000 Aug 12;356(9229):526-7.

doi: 10.1016/S0140-6736(00)02573-3.

Author

E A Gale¹

Affiliation

¹ Department of Diabetes and Metabolism, Southmead Hospital, Bristol, UK.

PMID: 10950225
DOI: 10.1016/S0140-6736(00)02573-3

No abstract available

PubMed Disclaimer

Comment on

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.
Chaillous L, Lefèvre H, Thivolet C, Boitard C, Lahlou N, Atlan-Gepner C, Bouhanick B, Mogenet A, Nicolino M, Carel JC, Lecomte P, Maréchaud R, Bougnères P, Charbonnel B, Saï P. Chaillous L, et al. Lancet. 2000 Aug 12;356(9229):545-9. doi: 10.1016/s0140-6736(00)02579-4. Lancet. 2000. PMID: 10950231 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information